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functionality of the accessory gene regulator (agr) quorum sensing system is an important factor 
promoting either acute or chronic infections by the notorious opportunistic human and veterinary 
pathogen Staphylococcus aureus. Spontaneous alterations of the agr system are known to frequently 
occur in human healthcare‑associated S. aureus lineages. However, data on agr integrity and function 
are sparse regarding other major clonal lineages. Here we report on the agr system functionality 
and activity level in mecc‑carrying methicillin resistant S. aureus (MRSA) of various animal origins 
(n = 33) obtained in Europe as well as in closely related human isolates (n = 12). Whole genome analysis 
assigned all isolates to four clonal complexes (cc) with distinct agr types (CC599 agr I, CC49 agr ii, 
CC130 agr III and CC1943 agr iV). Agr functionality was assessed by a combination of phenotypic 
assays and proteome analysis. in each cc, isolates with varying agr activity levels were detected, 
including the presence of completely non‑functional variants. Genomic comparison of the agr i–iV 
encoding regions associated these phenotypic differences with variations in the agrA and agrc 
genes. the genomic changes were detected independently in divergent lineages, suggesting that 
agr variation might foster viability and adaptation of emerging MRSA lineages to distinct ecological 
niches.
Methicillin-resistant Staphylococcus aureus (MRSA) is among the leading causes of opportunistic infectious dis-
eases in human and veterinary medicine  worldwide1,2. Mobile genetic elements (MGEs) originally denominated 
as staphylococcal cassette chromosome mec (SCCmec) cause horizontal spread of methicillin resistance among 
 staphylococci3, with either mecA or mecC4,5 as the resistance-mediating gene. So far, thirteen distinct SCCmec 
elements have been described, including the mecC-harbouring element SCCmec  XI5,6. When these MRSA were 
first isolated from specimens of human and ruminant hosts back in  20117–9, detection and verification of mecC 
was challenging due to the limited sequence similarity to mecA and its common association with a moderate 
or even low minimal inhibitory concentration (MIC) for  oxacillin5,9–11. Since then, mecC-MRSA were not only 
open
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found in samples from humans and dairy  cattle5,12, but also in domestic-, zoo-, and wild animals as well as 
in  wastewater8,10,13–15. Human cases of infection associated with mecC-MRSA were reported from the United 
Kingdom, Germany, Austria, Spain and many other European  countries7–9,16 suggesting that mecC-harbouring 
isolates have become  ubiquitous10,14.
Mechanisms enabling opportunistic bacteria to cross species barriers, to infect a new host or to enhance their 
viability in the environment are still poorly understood. Changes expected to be involved in (niche) adaptation 
processes of S. aureus encompass (among others) alterations of metabolic  pathways17, escape of host defence 
 mechanisms1, biofilm  formation18, iron acquisition  abilities19, generation of  pseudogenes20,21 or nucleotide 
changes altering promoter  structures22. In addition, production of  cytotoxins23,24 and other virulence factors as 
well as their regulation circuits might have a strong influence on host  adaptation23,25,26. Acquisition of specific 
virulence factors from a host-specific gene  pool1,27 by horizontal gene transfer as well as core genome diversifica-
tion contributes to broadening the host range of S. aureus27, leading to the definition of extended host spectrum 
 genotypes28.
In S. aureus, the accessory gene regulator (agr) locus represents a quorum sensing system that orchestrates 
the switch from expressing of surface associated factors (needed for initial attachment) to the expression of 
exotoxins at high cell density via the effector molecule  RNAIII29. Notably, agr activity appears to be essential for 
skin and soft tissue  infections30. Previous research demonstrated the important role of agr for virulence factor 
transcription in animal models of acute  infections31–33, while agr defective mutants seemed to be frequently 
associated with chronic  diseases34–39, persistent  bacteremia40 and cystic  fibrosis41, indicating adaptation of S. 
aureus to the infected  host42.
The staphylococcal agr locus is an autoinducing control unit that combines bacterial quorum sensing with 
a classical bacterial two-component regulatory system (TCRS) and the employment of a regulatory RNA (i.e. 
RNAIII) as effector  molecule29. The locus consists of two divergently arranged transcription units, which are 
transcribed from promoters P2 and P3, respectively. The P2-derived RNAII harbours the agrBDCA operon, 
while P3 drives transcription of RNAIII. In S. aureus, the cell–cell communication (i.e. quorum sensing) depends 
mainly on autoinducing, short peptides (AIPs) encoded by agrD, which are exported by the transmembrane 
endopeptidase (AgrB) and finally trimmed by a type I extracellular signal peptidase (SspB; reviewed  in43). At 
sufficient extracellular AIP concentrations, the peptides binds to the sensor histidine kinases (AgrC) which 
then phosphorylates the response regulator AgrA (AgrA-P)43,44. While a weak baseline transcription from the 
P2 and P3 promoters is detectable even in the absence of AgrA-P43,44, the activated transcription factor strongly 
(auto)induces expression of both agrBDCA and  RNAIII44. In addition, AgrA-P directly leads to transcription of 
phenol-soluble modulin (PSM) genes. The majority of agr-regulated genes, however, is controlled via RNAIII 
which influences their transcription and  translation29,43,45. RNAIII represents a dual-function regulatory RNA 
that harbours, in addition to its base-pairing functions, a small open reading frame (hld) encoding staphylococcal 
delta-haemolysin (Hld). The hld Shine-Dalgarno site was shown to be accessible to ribosomes, indicating that 
hld represents a translatable unit on the RNAIII  molecule46, which in turn makes Hld detection a suitable proxy 
to determine RNAIII expression and Agr activity in general.
S. aureus virulence often depends on the secretion of large amounts of toxins, including exotoxins with 
superantigenic functions, i.e., the staphylococcal enterotoxins (SEA, SEB, etc.) and toxic shock syndrome toxin 
(TSST-1)47. Expression of ordinary virulence determinants such as proteases, lipases or nucleases, are promoted 
by an activated agr system, whereby expression of surface binding proteins is downregulated. Nonetheless, this 
generalized summary still includes exceptions and lineage-specific  differences48. In addition, primary transcrip-
tion regulation of virulence factors not encoded by the core genome, e.g. genes associated with the enterotoxin 
gene cluster (egc) harbouring staphylococcal enterotoxins (SE), appears to be less depending on increased agr 
 activation49.
Biofilm formation is another important feature in S. aureus pathogenesis which is influenced by agr. The effect 
of a cellular increase of the agr transcript RNAIII, however, is not entirely clear. While previous studies dem-
onstrated enhanced biofilm formation in agr deficient  strains42,50, recent reports, focusing on non-lab-adapted 
strains, found lineage-specific  differences51, or a variable role of the agr  system38,52.
Occurrence of independent genomic changes in divergent clonal lineages is generally considered to reflect 
the adaptation power of bacteria to changing  environments53. Aim of the study presented here was to analyse 
the genome structures of emerging mecC-MRSA isolates of animal and human origin with the overarching goal 
to identify genomic patterns that might be associated with the adaptation of such strains to novel hosts and 
ecological niches. While differences in exotoxin and virulence factor endowments of the isolates were mainly 
associated with distinct clonal complexes (CC), we found independent genomic variations of the agr locus across 
different mecC-MRSA clonal lineages. These changes were associated with varying agr activity patterns and 
kaleidoscopic phenotypes regarding haemolysis and biofilm architecture, suggesting a role of the agr system in 
niche adaptation of the isolates.
Materials and methods
Sample collection and pre‑screening. Staphylococcus aureus isolates obtained from samples of various 
animal species were collected from January 2014 to December 2016 by IDEXX Laboratories in Ludwigsburg, 
Germany. Inclusion criteria for isolates were (1) a methicillin resistant phenotype based on growth in the pres-
ence of 6 μg/ml cefoxitin according to the manufacturer’s VITEK 2 Advanced Expert System (Nürtingen, Ger-
many) instruction together with (2) oxacillin MICs < 4 µg/ml, as reported for mecC-MRSA  before14. Isolates 
from seven different European countries were included. Species identity and methicillin resistance mediated by 
mecC was confirmed by PCR as described  elsewhere54. Antimicrobial susceptibility testing (AST) was carried 
out using the VITEK 2 system (BioMérieux, Germany) according to the standards given by CLSI VET01-A4 
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and M100-S2455,56. For comparative analysis, additional 12 mecC-positive isolates of human origin belonging to 
corresponding clonal backgrounds collected by the national reference laboratory for staphylococci at the Robert 
Koch Institute in Germany were included (Table 1).
Whole genome sequencing and genomic analysis of mecc‑MRSA. MRSA isolates positive for 
mecC were whole-genome sequenced (WGS) using Illumina MiSeq 300  bp paired-end sequencing with an 
Table 1.  Isolate characteristics of 45 mecC-MRSA. Isolate characteristics of 45 mecC-MRSA showing low or 
moderate oxacillin MICs while being able to grow in the presence of 6 μg/ml cefoxitin. ID, isolate identification 
number (this study); Original-ID, original isolate identification number; MLST, multilocus sequence type; spa, 
spa type based on allelic variants of the gene encoding protein A; AC, abdominal cavity; TC, thoracic cavity; 
UTI, urinary tract infection; n.a., not assigned.
ID Original-ID Sample source Host Country MLST spa Oxacillin MIC µg/ml
IMT31818 VB971510 Nose Dog Germany ST599 t278 1
IMT31819 VB971922.1 Uterus Horse Germany ST130 t843 0.5
IMT32509 VB985303 Wound Cat Germany ST599 t278 1
IMT32510 VB992333 Ear Cat Poland ST130 t843 1
IMT32513 VB998882.1 Ear Cat Germany ST599 t16473 1
IMT32929 VB962079.2 Wound Cat Netherlands ST130 t1519 0.5
IMT34478 VB994753.1 Nose Cat Germany ST130 t843 2
IMT34479 VB962798.2 AC Dog Germany ST130 t9165 0.5
IMT34480 VB962790 Ear Rabbit Germany ST130 t9165 1
IMT34485 VB982561.3 Wound Dog Germany ST2361 t10855 1
IMT34488 VB989315 Skin Cat Germany ST130 t843 2
IMT34489 VB993969 Wound Cat Germany ST130 t843 0.5
IMT34491 VB963607.2 Wound Cat Germany ST130 t843 2
IMT36943 VB973587.1 Ear Cat Germany ST599 t278 2
IMT36945 VB972803.2 Frontal sinus Cat Italy ST49 n.a 0.5
IMT36946 VB981317 Wound Cat Germany ST130 t843 2
IMT36947 VB986304 Wound Cat Switzerland ST599 t5930 1
IMT36948 VB987750 TC Cat Germany ST599 t5930 1
IMT36950 VB960116 Skin Cat Germany ST130 t843 2
IMT36952 VB978601 Wound Cat Germany ST2361 t3391 0.5
IMT38113 VB902052 Nose Cat Germany ST2361 t3391 2
IMT38115 VB968721.3 Abscess Cat Sweden ST130 t373 2
IMT38116 VB949481.1 Nose Hedgehog Germany ST599 t278 2
IMT38119 VB972539 Skin Cat Germany ST1764 t524 0.5
IMT39816 PF169945.2 Tissue Cat France ST1245 n.a 0.5
IMT39819 VB945444 Faeces Sheep Germany ST130 t843 2
IMT39820 VB911819.2 Wound Hedgehog Germany ST2361 t3391 2
IMT39824 VB950088.2 Nose Cat Germany ST599 n.a 0.5
IMT39825 VB957945 Nose Dog Germany ST599 t12332 2
IMT40504 BF136317 Nose Cat France ST1943 t8835 1
IMT40506 VB966538 Wound Cat Germany ST130 t843 2
IMT40507 VB966063.1 Wound Cat Germany ST2361 t2345 2
IMT41554 VB999839.3 Wound Cat Germany ST130 t1736 2
RKI5962 14-03729 Ulcus cruris Human Germany ST599 t12332 0.5
RKI5963 13-00970 Wound Human Germany ST599 t5930 0.5
RKI5964 16-02552 Wound Human Germany ST599 t9925 ≤ 0.25
RKI5965 14-02098 Abscess Human Germany ST1245 t13902 0.5
RKI5966 15-00967 Wound Human Germany ST130 t14848 0.5
RKI5967 16-01171 Wound Human Germany ST130 t15938 0.5
RKI5968 10-00991 Wound Human Germany ST130 t1736 0.5
RKI5969 13-03754 Wound Human Germany ST2361 t3391 1
RKI5970 18-00258 Infection Human Germany ST2361 t3391 1
RKI5971 18-00326-1 UTI Human Germany ST2361 t3391 1
RKI5972 19-00523 Unknown Human Germany ST49 t208 1
RKI5973 19-00418 Abscess Human Germany ST2361 t2345 0.5
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obtained coverage > 90X. Raw reads were used for de novo assembly into contiguous sequences (contigs) and 
subsequently into scaffolds using SPAdes v3.1257. Assembled draft genomes of the isolates were annotated using 
 Prokka58. WGS data were used for genotypic characterization including the determination of the sequence type 
(ST) (MLST v2.0)59. Genomic sites of interest and genes encoding for major regulators including the accessory 
gene regulator (agr) system were investigated using Geneious 11.1.5 (Biomatters Ltd., Australia)60. Genomic 
data were further analysed with ResFinder-2.2 (threshold: 90% ID, 80% minimum length), VirulenceFinder-1.6 
(threshold: 95% ID, 80% minimum length) and spaTyper59,61–63.
In order to compare the genomes at high resolution, we used the maximum common genome (MCG) that 
is defined by those orthologous genes present in all  genomes64. The coding sequences were clustered based on 
the parameters of nucleotide sequence similarity (≥ 90%) and gene coverage (≥ 90%). The MCG was defined as 
those genes that were present in each genome and fulfilled the threshold parameters, yielding 2,094 genes. Allelic 
variants of these genes were subsequently extracted from all genomes by a blast-based approach, then aligned 
individually for each gene and concatenated, resulting in an alignment of 1.95 Mbp for these isolates. The align-
ment was used to generate a maximum likelihood phylogenetic tree using RAxML 8.2.965 which was visualized 
together with the distribution of the accessory gene content using  phandango66.
phenotypical assessment of accessory gene regulator (agr) activity. In this study, complemen-
tary phenotypical methods including colony spreading and haemolysin production were employed to investigate 
the activity of the agr system. Synergistic production of different haemolysins (SPDH) on columbia agar plates 
(Oxoid, Germany) supplemented with 5% sheep blood (SBA) was investigated by cross-streaking tested bacteria 
perpendicularly to laboratory strain S. aureus RN4220 as described  before1. RN4220 is characterized by a strong 
β-haemolysin production while α-haemolysin secretion is missing and PSM α peptides are produced only at 
non-considerable  amounts35, 67,68. Of note, RN4220 was reported to produce the α-haemolysin encoding mRNA 
(hla), indicating that hla transcription cannot necessarily be correlated with α-haemolysin production and/or 
secretion in S. aureus69. In addition, the capacity to cause synergistic haemolysis with β-haemolysin is to a large 
extend due to AgrA-induced expression of  PSMs67, while β-haemolysin inhibits α-haemolysins’ effect on  SBA35. 
After overnight incubation of the plates at 37 °C, the haemolysis zones were examined and pictures were taken.
A modified CAMP test for verification of β-haemolysin production was performed using Streptococcus agalac-
tiae (ATCC12386) and the β-haemolysin producing S. aureus strain ATCC25923 (positive control) as described 
 recently1. Briefly, staphylococci of interest were streaked perpendicularly to CAMP-factor producing ATCC12386. 
A positive interaction of CAMP-factor from Group B streptococci with β-haemolysin (phospholipase C) of S. 
aureus is characterized by completely lysed sheep blood erythrocytes forming a clear semilunar-shaped  area70.
We also performed a colony spreading assay on soft agar described by Kaito et al.71, since an activated state 
of the agr  system72 as well as AgrA-depending production PSM α3 are necessary for S. aureus to slide on wet 
 surfaces73. Beyond that, a mutation in the membrane-bound transpeptidase sortase A (SrtA), or for instance 
the lack of its substrates fibronectin binding protein A and B (FnBPA, FnBPB), clumping factor A and B (ClfA, 
ClfB) enhances  spreading74. Briefly, 20 ml tryptic soy soft agar plates (0.24%) were used to investigate spreading 
activity of all MRSA. After overnight incubation of the plates at 37 °C, the spreading zones were examined, and 
pictures were taken.
The standard laboratory strains USA300 (FPR3757), the USA300 agrA::Tn mutant (NE1532) and RN4220 
were included in all phenotype assays as controls for wild type (wt) agr functionality, a loss-of-function- and a 
functionally impaired agr system,  respectively69. In lab strain RN4220, a frameshift mutation in the agrA-coding 
region adds three amino acids to the C-terminus of AgrA, a variation known to cause a considerable delay in 
RNAIII transcription compared to the wild  type70. To verify production of TSST, the TST-RPLA Kit TD940 
(Thermo Fisher Scientific, USA) was used according to the manufacturer’s instructions.
All surveys were repeated thrice for each of the isolates including the reference strains.
Proteomic analysis of α‑, β‑ and δ‑haemolysin production in mecc‑MRSA. Protein abundance 
values for Hla/Hlb/Hld from whole bacterial cell preparations were measured to assess RNAIII transcription 
capabilities by Hld production and Hla and Hlb (pre-) proteins of the bacteria and their general ability to pro-
duce them.
Sample preparation by easy extraction and digestion (SpeeD). Samples were prepared in trip-
licates using SPEED as previously  described75. In brief, cells were re-suspended in trifluoroacetic acid (TFA) 
(Uvasol for spectroscopy, Merck, Darmstadt, Germany) (sample/TFA 1:4 (v/v)) and incubated at 70 °C for 3 min. 
Samples were neutralized with 2 M TrisBase using 10 × volume of TFA and further incubated at 95 °C for 5 min 
after adding Tris(2-carboxyethyl)phosphine (TCEP) to a final concentration of 10 mM and 2-Chloroacetamide 
(CAA) to a final concentration of 40 mM. Protein concentrations were determined by turbidity measurements 
at 360 nm, adjusted to 0.25 µg/µl using a 10:1 (v/v) mixture of 2 M TrisBase and TFA and then diluted 1:5 with 
water. Digestion was carried out for 20 h at 37 °C using Trypsin (Promega, Fitchburg, WI, USA) at a protein/
enzyme ratio of 50:1. Resulting peptides were desalted using StageTips  C1876.
Liquid chromatography and mass spectrometry. Peptides were analyzed on an EASY-nanoLC 
1,200 (Thermo Fisher Scientific, Bremen, Germany) coupled online to a Q Exactive™ Plus mass spectrometer 
(Thermo Fisher Scientific, Bremen, Germany). 1 µg peptides were loaded on an Acclaim PepMap trap column 
(20 mm × 75 μm i.d., 100 Å, C18, 3 μm; Thermo Fisher Scientific, Bremen, Germany) and were subsequently 
separated on a 200 cm μPAC column (PharmaFluidics, Ghent, Belgium). The flow rate was set to 800 nl/min and 
a stepped 40 min gradient was applied: 3–10% B in 4 min, 10–33% B in 17 min, 33–49% B in 4 min, 49–80% B 
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in 7.5 min and 80% B for 7.5 min. Solvent A was 0.1% (v/v) formic acid (FA) in water, solvent B consisted of 80% 
(v/v) acetonitrile in 0.1% (v/v) FA.
The Q Exactive Plus was operated in data-independent (DIA) manner in the m/z range of 350–1,150. Full 
scan spectra were recorded with a resolution of 70,000 using an automatic gain control (AGC) target value of 
3 × 106 with a maximum injection time of 100 ms. The Full scans were followed by 53 DIA scans of dynamic 
window widths using an overlap of 0.5 Th (Supplemental Table 1). DIA spectra were recorded at a resolution of 
17,500@200 m/z using an AGC target value of 3 × 106 with a maximum injection time of 55 ms and a first fixed 
mass of 200 Th normalized collision energy (NCE) was set to 25% and default charge state was set to 3.
Mass spectrometric data analysis. The mass spectra were searched in DIA-NN (Version 1.7.6)77 using 
the deep-learning based spectra and RT prediction for sequences from the complete proteome of S. aureus strain 
NCTC 8,325 (UP000008816, 2,889 sequences, downloaded 4/10/18) and sequences of selected genes (hla, hlb 
and hld) obtained from whole genome sequencing. Spectra were searched with a tolerance of 10 ppm in  MS1 
and 20 ppm in  MS2 mode, strict trypsin specificity (KR not P) and allowing up to one missed cleavage site. 
Cysteine carbamidomethylation and N-terminal methionine excision were set as modifications. Peptide length 
was restricted to 7–30 amino acids. The m/z ranges were 350–1,150 for full scans and 200–1,800 for DIA scans. 
A false discovery rate of 1% was applied for precursor and protein identifications.
Biofilm formation assay on polystyrene tissue culture plates. Biofilm formation to inert artificial 
surfaces was tested in 96‐well polystyrene tissue culture plates (Greiner Bio‐One, Cellstar, F‐form) as described 
 previously78. Briefly, S. epidermidis RP62A and S. carnosus TM300 were used as positive and negative controls, 
respectively. Bacterial overnight cultures in triplicates were grown in Trypticase Soy Broth (TSB; Becton Dickin-
son) which contains, according to the standard composition, 2.5 g/l glucose. Cultures were diluted in fresh TSB 
to an  OD600 of 0.05 and 200 µl filled in each well (four wells per biological replicate) and incubated under static 
condition at 30 °C for 18 h. Supernatant was discarded and adherent cells were washed twice with 1 × PBS buffer 
before the remaining cells were heat-fixed at 65 °C for 1 h. Plates were then stained with 10 mg/ml crystal violet 
for 2 min, washed twice with double-distilled water before proceeding with measuring the absorbance at  OD492 
by an ELISA plate reader (Multiskan Ascent).
Imaging of the biofilm architecture by confocal laser scanning microscopy (CLSM). In order 
to study the putative effect of different agr non-wt variants on growth/biofilm characteristics on glass surfaces, 
overnight cultures of closely related isolates were subjected to comparative analysis: S. aureus isolates belonging 
to CC130 IMT38119 (agr III wt), RKI5966 (agr III non-wt AgrC variant) and IMT31819 (agr III non-wt AgrA 
variant) were diluted to  105 bacteria per ml. One milliliter diluted suspension was used to inoculate the wells 
of a 24-well plate with glass bottom (µ-Plate 24 Well Black, ibidi GmbH, Germany), which was then cultivated 
for 20 h at 37  °C with 150 rpm on an orbital shaker. Afterwards, samples were photographed (Lumix GM1, 
Panasonic, Japan) on a light table, stained with LIVE/DEAD (LIVE/DEAD Cell Viability Assay, ThermoFisher 
Scientific, Germany) according to the manufacturer’s instructions and imaged with a confocal laser scanning 
microscope (LSM780, Carl Zeiss AG, Germany) using the Plan-Apochromat 20 × /0.8 objective.
When necessary, images were cropped, adjusted for optimal brightness and contrast (applied to the whole 
image) using Adobe Photoshop CS6 (Adobe Systems, San Jose, CA, USA).
Database accession numbers. Genomic sequencing data used are available for download from the 
National Center for Biotechnology Information (NCBI) under BioProject accessions PRJNA588740. Accession 
numbers of whole genomes sequences are provided in Supplemental Table 2. The mass spectrometry proteomics 
data have been deposited to the ProteomeXchange Consortium (https ://prote omece ntral .prote omexc hange .org) 
via the PRIDE partner repository with the dataset identifier PXD016486.
Results
General features of the mecc‑MRSA strain collection. A total of 33 mecC-MRSA were obtained 
from seven different European countries and six different animal species for whole genome sequencing (WGS). 
Isolates from cats dominated the collection (24/33), followed by those obtained from dogs (4/33) and other 
companion-, wild- and livestock animals (Table 1). We also included 12 isolates from human patients belong-
ing to matching genotype lineages (Table 1, Fig. 1) for further phenotype assays and subsequent comparative 
genome analysis. All 45 isolates displayed low or moderate oxacillin MICs < 4 µg/ml, while being able to grow in 
the presence of 6 μg/ml cefoxitin (Table 1), which is typical for mecC-MRSA14, 79. AST results revealed additional 
resistance to aminoglycosides (gentamicin, kanamycin) for isolate RKI5962 only. A positive latex agglutination 
test verified production of the TSST toxin for all isolates harbouring a tst-bov  variant80. Interestingly, we noticed 
considerable phenotypic differences regarding haemolysis on SBA between the isolates, even among those shar-
ing the same phylogenetic background. This prompted further investigations into putative genomic changes 
which might account for these variations.
phylogenetic relationship and distribution of virulence‑associated factors among 
mecc‑MSRA. WGS of the isolates revealed that the 45 mecC-positive MRSA belonged to four CCs: CC599 
(12), CC130 (21), CC1943 (10) and CC49 (2) (Table 1, Fig. 1). Pairwise SNP-distances between the core genomes 
were calculated for all MRSA isolates (Supplemental Table 3), showing a very close phylogenetic relationship of 
those genomes belonging to the same CC. While the differences within one clonal complex ranged between 100 
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and 500 SNPs, the genomes belonging to different CCs differed by more than 10,000 SNPs, resulting in a clear 
clustering of MRSA from the same CC (Fig. 1). Metadata such as geographic origin, disease or animal species 
showed no significant association with the core genome clustering, but a lineage-specific association of the vari-
able gene content was obvious (Fig. 1).
Nevertheless, a core  set81 of S. aureus virulence factors was present in all isolates, including aureolysin (aur), 
bi-component leukotoxin (lukD/E), γ-haemolysin components A–C (hlgA, hlgB, hlgC) and genes encoding 
for the serine proteases SpIA and SpIB. Presence of the epidermal cell differentiation inhibitor B (edinB) and 
exfoliative-like toxin  D282 was associated with CC130. When considering factors promoting biofilm produc-
tion in S. aureus, all isolates harbour complete ica loci (icaR/icaADBC) but not the biofilm-associated surface 
protein bap. For iron acquisition, all isolates harboured amongst others the iron-regulated surface determinant 
gene cluster isdABCDEF.
While only one isolate lacked the gene encoding α-haemolysin (hla) completely, three isolates belonging 
to CC130 carried hla variations which resulted in aa sequence alterations and two further isolates harboured 
insertions (details are provided in Supplemental Table 4). Bacteriophages converting the β-haemolysin gene 
(hlb) were identified in four isolates (for details see Supplemental Table 4). Some of the mecC-MRSA, especially 
those belonging to CC599 and CC1943 harboured variants of previously described staphylococcal pathogenicity 
islands, including SaPIbov80 encoding SEC, a TSSTbov variant and SElL (Fig. 1). Isolates belonging to CC1943 
Figure 1.  The core genome phylogeny based on the Maximum Common Genome. The core genome phylogeny 
based on the Maximum Common Genome comprising 2,094 orthologous genes present in all isolates show 
four distinct clusters, whereby the genetic diversity within the clusters is rather low. Furthermore, the isolates 
metadata show no significant association with the core genome clusters. The 2,003 accessory genes show a 
distribution pattern that is highly correlated with the core genome clusters (right side), suggesting a lineage-
specific gene content. Genes for aureolysin (aur), leucotoxins D and E (lukD, lukE), gamma-haemolysin 
component A–C (hlgA, hlgB, hlgC) and proteases SpIA or SpIB are present in all isolates. All isolates belonging 
to ST-1943 as well as some CC130 and CC599 were positive for different variants of the Staphylococcal 
pathogenicity island (SaPI) harbouring a toxic shock toxin encoding gene (tst), which were variants of tst-
bov80. Moreover, 48.5% of the mecC-positive isolates harboured staphylococcal enterotoxins (SE). The protease 
SpIE can just be found in 23/33 isolates and is not associated with any sequence type. The epidermal cell 
differentiation inhibitor B (edinB) cannot be determined in the isolates of ST-1943, ST-2361, ST-49 and ST-599.
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were positive for an egc cluster variant (seg, sei, selm, seln, selo, selu), while all isolates were positive for selX 
(Fig. 1). Furthermore, all isolates were positive for intact and identical genes encoding phenol-soluble modulins 
(PSM α1 to PSM α4 and PSM β1 and PSM β2), and differences in the promoter regions of these operons seemed 
to particularly mirror the genomic lineage (data not shown).
mecC‑MRSA belonging to CC599, CC49, CC130 and CC 1943 harbour agr variations. According 
to the typing scheme used by Shopsin et al.83, CC599 MRSA were assigned to the agr type I, CC49 to type II, 
CC130 to type III and CC1943 to type IV. Of the isolates harbouring the type I agr system, two isolates showed aa 
changes for AgrA and all AgrB aa sequences showed the variation A182T when compared to the S. aureus strain 
N315 sequences (Supplemental Table 4), while the respective aa sequences for AgrC and AgrD were identical 
(Fig. 2). All isolates belonging to CC599 and CC49 showed a nucleotide insertion (T) at bp 55 within the region 
encoding RNAIII, resulting in 514 + 1 bp length and an additional uracil (U) in the hairpin 2, according to the 
secondary structure model of RNAIII proposed by Benito and  colleagues46. Since this insertion was found in all 
isolates associated with the agr types I and II in this study, this variation was considered as the wild type (wt) 
sequence here. Only two isolates belonged to the agr type II, and variation among them was detected in terms of 
a premature stop codon created by an insertion in the AgrA encoding gene in isolate IMT36945 (Fig. 2). Most 
variants were detected among the aa sequences for AgrA (one insertion, two changes) and AgrC (four changes) 
of the CC130 isolates harbouring the type III agr system (Fig. 2, and Supplemental Table 4). For the CC1943 iso-
lates (type IV agr), only IMT36952 showed an aa sequence variation in AgrA (Fig. 2). The nucleotide sequence 
regions encoding for the 26-aa δ-haemolysin integrated in RNAIII and the promoter sequences for RNAII (P2) 
and RNAIII (P3) were conserved in all 45 genomes investigated here (Fig. 2a–d).
Assessment of genes associated with virulence factor transcription in mecc‑MRSA. Only in 
isolate IMT41554 (CC130), a C to T change within the − 35 promoter region previously identified as the AgrA 
binding region of the psm α  operon84 was detected at position − 27. As the phenotype did not deviate from 
closely related isolates, this single nucleotide change is unlikely to affect the AgrA-binding abilities upstream of 
psm α1–4 in IMT41554. Yet, many two component regulatory systems (TCRS) and nucleic acid-binding pro-
teins seem to modulate S. aureus virulence factor expression, especially of exotoxins with haemolytic  activity85. 
Since TCRS variations might influence the particular phenotype appearance of S. aureus, the isolate collection 
was screened for obvious deletions, insertions or changes generating for instance amino acid (aa) substitutions 
or premature stop codons. Among the TCRS included in the analysis were those either positively or negatively 
influenced by agr such as the staphylococcal accessory regulator nucleic acid-binding protein (SarA) and the 
regulator of toxins (Rot). Overall, amino acid changes (referred to the respective reference sequence) in global 
regulators were rare and mostly lineage-specific (Supplemental Table 5), indicating a limited role of these varia-
tions for the phenotype differences observed for each CC.
Haemolysis and colony spreading of mecc‑MRSA carrying agr variations. While analysing the 
mecC-MRSA belonging to four different phylogenetic lineages, we noticed a broad range of different phenotypes 
with respect to haemolysis on SBA plates.
Initially, haemolytic activities were assessed using a SPDH cross-streaking test utilizing strain RN4220 (Fig. 3). 
Here, only 30 of 45 isolates showed the typical haemolysis pattern for α-, β- and δ-haemolysin production (Fig. 4, 
Supplemental Figures 1 and 2), suggesting that some of the isolates might harbour genomic alterations affect-
ing haemolytic activities (Table 2). We then used the CAMP test which indicates secretion of β-haemolysin by 
S. aureus through a characteristic arrow-shaped synergistic haemolysis zone on SBA. 10/45 isolates and two of 
the reference strains failed to produce the corresponding phenomenon (Table 2, Supplemental Figure 1), with 
four isolates (and two reference strains) harbouring a phage disrupting the hlb gene (Supplemental Table 4). The 
remaining six isolates lacked the hlb-converting phage but showed instead AgrA variations that clearly deviated 
from the wildtype (Fig. 2, Supplemental Table 4).
Since functionality of the agr system is also reflected by the ability of S. aureus to slide over wet  surfaces72, we 
performed a colony spreading assay on semisolid agar plates. As a result, 38/45 isolates showed the character-
istics of “sliding bacteria”, which are exemplarily shown in Fig. 5. A comprehensive summary of all phenotype 
characteristics of the isolate collection and the reference strains included is presented in Table 2.
Agr activity assessment by measuring δ‑haemolysin production in mecc‑MRSA using prot‑
eomics. The protein abundance of Hld (δ-haemolysin) was used to assess RNAIII transcription capabilities 
of S. aureus isolates, as the corresponding coding gene (hld) is integrated in the RNAIII transcript. Hld abun-
dance was measured using whole cell proteomics to cover the actual expression level. Therefore, the assessment 
of direct whole-cell δ-haemolysin production appears as a suitable method to predict RNAIII transcription, as 
long as occurring sequence variations do not affect the hld encoding gene or the promoter regions in in the agr 
operon (Figs. 2 and 4a).
The protein abundance levels for δ-haemolysin measured by mass spectrometry are shown in Supplemental 
Table 6, and putative CC-specific differences were noticed (Fig. 4a). Isolates sharing the CC1943 background and 
lacking agr alterations, for example, showed higher overall δ-haemolysin abundance values than those belonging 
to CC130 or CC8 (Supplemental Table 6, Fig. 4a). Based on the δ-haemolysin detection level, we categorized the 
individual isolates’ agr activity as follows: 0, lack of detectable agr activity; +, weak agr activity and ++, strong 
agr activity (Fig. 4a). The reference strains included showed Hld abundances which clearly correlate with their 
previously reported agr functionality: For RN4220, a delay towards production of Hld due to an agrA mutation 
is  known86. This alteration is also mirrored by a decreased protein abundance (Fig. 4a) and was consequently 
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considered as “weak” agr activity. Moreover, the USA300 agrA::Tn strain (NE1532) completely lacked Hld detec-
tion, as expected. Thus, detection of Hld production together with a genomic inspection of the agr encoding 
region is indeed suitable to predict RNAIII transcription and agr functionality.
comparison of phenotype assay results and haemolysin abundances. We then plotted the prot-
eomic data against the results obtained from the phenotype assays described above.
The δ-haemolysin protein abundance and haemolysis phenotype associated with the isolates and reference 
strains are shown in Fig. 4a. Strikingly, all isolates (and reference strains) showing a strong reduction or lack of 
δ-haemolysin production were found to carry non-wt variants of either AgrA or AgrC (Fig. 4a). In addition, 
these AgrA or AgrC non-wt variants were associated with non-wt haemolysis patterns, too (Table 2, Supple-
mental Table 4, Fig. 4a).
The results for β-haemolysin (Hlb) protein abundances and the isolates’ capability to produce a synergistic 
haemolysis (CAMP phenomenon) are presented in Supplemental Figure 2 and Table 2, with isolates harbouring 
phage-disrupted hlb genes and agr alterations being indicated. Interestingly, all isolates with non-wt AgrA vari-
ants also failed to produce the CAMP phenomenon, even when whole-cell β-haemolysin abundance levels (e.g. 
for IMT36945) were obviously sufficient to induce the phenotype in matching agr wt isolates (e.g. RKI5972). Two 
further isolates harbouring non-wt variants of AgrC (IMT32510 and IMT32929) produced only a weak CAMP 
phenomenon (blue dots in Supplemental Figure 2). Thus, a functionally active agr system seems to be necessary 
for S. aureus to produce the exhibit CAMP phenomenon on SBA.
When comparing the results of whole-cell α-haemolysin detection with the haemolysis phenotypes obtained 
by the SPDH test we noted considerable discrepancies. Thus, we clearly found Hla protein production in some 
of the isolates harbouring AgrA and AgrC variations, but the strains did not exhibit an α-haemolysin phenotype 
on SBA (Fig. 3 and Supplemental Figure 1). Vice versa, in five isolates showing α-, β-, δ-haemolysin activity on 
SBA (blue dots in Supplemental Figure 1), no Hla protein levels were detectable. This could for instance be a 
result from repeated mis-judgement of the phenotype, from significant differences for Hla abundances between 
proteome- and secretome or the detection limit of the mass spectrometry. Of note, the α-haemolysis phenotype 
was absent in all isolates harbouring AgrA or AgrC variants (Supplemental Figure 1), again indicating that a 
functional agr system is required for inducing an α-haemolysis zone on SBA.
Finally, colony spreading on wet surfaces is known to be directly induced by AgrA-P. As shown in Table 2, 
all isolates lacking this feature displayed non-wt variants of AgrA or AgrC, while some of the isolates with AgrA 
or AgrC variants were still capable to spread (Figs. 4b,5).
Agr variation is not associated with differences in biofilm formation on polystyrene tissue cul‑
ture plates. All 45 mecC-MRSA isolates were tested for their ability to form stable biofilms on the inert 
surfaces of polystyrene tissue culture plates in a standard crystal violet-staining assay. The test allows for the 
detection and quantification of sturdy biofilms that are firmly attached to artificial surfaces and which are not 
removable by washing. With respect to the 12 isolates belonging to CC599, only two (IMT36947 and IMT36948) 
formed a visible biofilm (value-1-biofilm) in the crystal violet assay (Table 2, detailed information in Supplemen-
tal Table 7). Among the 21 CC130 isolates, 12 were biofilm negative (value-0-biofilm), eight displayed moderate 
biofilm levels (value-1-biofilm) and one isolate produced a strong biofilm (value-2-biofilm). In addition, two 
out of ten CC1943 mecC-MRSA were strong biofilm producers (value-2-biofilms), while the remaining isolates 
lacked this ability completely. Summarizing the results of Table 2 and Supplemental Table 3, neither the agr type 
nor the non-wt variants of AgrA or AgrC were attributable to the ability to form a stable, non-removable biofilm 
on inert polystyrene surfaces.
Figure 2.  Sequence alignments of agr regions in mecC-MRSA. Sequence alignments for (a) CC599 (agr I), (b) 
CC49 (agr II), (c) CC130 (agr III) and (d) CC1943 (agr IV) isolates. First row shaded in yellow indicates the 
wild type (wt) exemplarily shown for all isolates sharing 100% coverage and 100% nucleotide and amino acid 
sequence identity. For each of the non-wt isolates on the display, changes within the upper gray line indicates 
a nucleotide sequence alteration while changes in the second line indicates amino acid sequence alteration. 
For all details and the reference sequences used for each CC see Supplemental Table 4. (a) First row, wt agr I in 
CC599 shared by IMT32509, IMT32513, IMT36943, IMT 36,947, IMT36948, IMT38116, IMT39825, RKI5962, 
RKI5963 and RKI5964. Second row, IMT31818 has a triplet nucleotid deletion resulting in ΔN177 in AgrA; 
third row, IMT39824 shows a non synonymous substitution (from A to G in position 289) leading to F196S in 
AgrA. (b) First row, wt agr II in CC49 represented by RKI5972 while the second row shows IMT36945 with 
an insertion creating a premature stop codon in AgrA. (c) First row, wt agr III in CC130 shared by IMT34480, 
IMT34488, IMT34491, IMT36946, IMT36950, IMT38115, IMT38119, IMT39816, IMT39819, IMT40506, 
IMT41554, RKI5965, RKI5967 and RKI5968. Rows 2, 4, 9 and 10 show amino acid variations in AgrC for 
IMT34479 (N5S), RKI5966 (Q16H), IMT32929 (E216K) and IMT32510 (G284D) generated by corresponding 
non-synonymous substitutions. RKI5967 (row 3), IMT38119 (row 5) and IMT38115 (row 6), harbour a 
nucleotide substitution (c to a) at position -2 upstream the RNAIII sequence start, respectively. Rows 7, 8 and 11 
harbour variants of AgrA for IMT34489 (G68D), IMT34478 (S215P) caused by non-synonymous substitutions 
and IMT31819 shows an insertion at position 711 bp in agrA causing an alternate stop codon. (d) First row, 
WT agr IV in CC1943 shared by RKI5973, IMT34485, IMT40507, IMT40504, IMT38113. Second to fourth 
row (upper gray line) show a synonymous substitution (a to t at position 442) in agrA for RKI5971, RKI5970 
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AgrA and AgrC variations influence biofilm architecture. While the crystal violet-staining assay 
exclusively detects robust biofilms that remain permanently attached to surfaces upon washing, CLSM imaging 
allows for monitoring the biofilm development in situ. By this approach, even delicate interactions of bacterial 
communities on surfaces can be visualized. In order to elucidate the potential impact of agr functionality on 
biofilm architecture, we selected three representative isolates of the CC130 carrying different genomic variants 
of agr (marked by * in Table 2 and Supplemental Table 4) and analyzed them by CLSM imaging. Although the 
selected isolates were biofilm-negative in the crystal violet-staining assay on polystyrene, they clearly displayed 
an in situ biofilm on glass slides during CLSM monitoring, with remarkable differences between the isolates. 
Thus, the biofilm of the Hld-producing isolate IMT38119 harbouring the CC130-wt agr system, formed a flat, 
dense biofilm that covered almost the entire area of the well (Fig. 6a,b). In contrast, isolate RKI5966 (a non-wt 
AgrC-variant lacking Hld production) built a dense, local aggregate on the slide (Fig. 6c), with the biofilm mass 
growing much higher than that of agr-WT isolate IMT38119 (i.e. 307 µm vs. 174 µm) (Fig. 6b,d). Similarly, 
isolate IMT31819, a non-wt AgrA variant lacking Hld production, also formed a local aggregate (Fig. 6e) and 
displayed a tall biofilm mass whose architecture, however, appeared less dense than those of the other two iso-
lates tested (Fig. 6f). The combined data suggest that the agr system may rather influence the biofilm architecture 
than the overall biofilm-forming capacity of S. aureus.
Figure 3.  Haemolytic activities of S. aureus isolates on sheep blood agar (SBA) plates. (a) Scheme for 
assessment of haemolytic activity based on Geisinger et al.118. The isolates were tested by cross-streaking 
perpendicularly to S. aureus RN4220 on sheep blood agar (SBA) plates. The turbid zone induced by β-haemolysin 
production of RN4220 enhanced lysis by δ-haemolysin and PSMs (clear zone at the intersection) and inhibited 
α-haemolysin (V-shaped zone at the intersection). (b) Haemolytic activity of mecC-positive S. aureus belonging 
to different agr types on SBA plates. The lack of a corresponding phenotype in the isolate collection is indicated 
by a grey rectangle. One exemplarily image was used to illustrate the differences, respectively.
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Discussion
Agr variants fine‑tune virulence levels in mecC‑MRSA belonging to CC130, CC1943, CC599 and 
CC49. In the past decade, MRSA have established both as commensals and as infectious agents in animals at 
alarming  rates87,88. In addition to classical mecA-carrying MRSA clonal lineages, emerging mecC-MRSA further 
add to this problem by affecting various animal species as well as humans, suggesting a broad host range of such 
 strains8,14,16. The mecC-MRSA isolates analysed in our study were found to belong to clonal complexes CC130, 
CC1943, CC599 and CC49, confirming the widespread occurrence of these lineages, at least in  Europe8, 14,16. 
Each of the four CCs harboured distinct isolates with altered agr loci, resulting in reduced or even total loss 
of agr activity. By employing mass spectrometry, we determined Hld production which served as a proxy for 
RNAIII transcription in our experiments. Agr functionality was further assessed by testing haemolysis on SBA 
and a colony spreading assay on semisolid agar whose accuracy for predicting Agr activity was shown  before35,71. 
Based on the δ-haemolysin amounts detected, the 45 isolates (and three reference strains) were assigned to dis-
Figure 4.  Illustration showing protein abundance values, relevant genomic variation and phenotype results 
of mecC-MRSA. (a) δ-haemolysin (Hld) protein abundance and the synergistic production of different 
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Table 2.  Phenotypic characterisics of mecC-MRSA. Genomic variation within the agr encoding region is 
indicated by use of bold ID letters (for details see Fig. 2). The isolates further investigated with respect to 
biofilm structures using CLSM are marked with *. Agr activity prediction according to Hld values presented 
in Fig. 4a (0, +, ++). ID, isolate number; CC, clonal complex; agr, accessory gene regulatory type; CS, colony 
spreading (phenotypical verification for agr functionality); CAMP, phenotypical verification for β-haemolysin 
production; SPDH, test results for synergistic production of different heamolysins using RN4220 (phenotypical 
verification of α-, β- and δ-haemolysin production); BF, biofilm formation (mean absorbance 492 nm; values: 
0, < 0.2811; 1, 0.2811 < x < 1.0; 2, > 1.0); + , positive; −, negative.
ID CC agr CS
Haemolysis on 
SBA
BF agr acitivity level (predicted)CAMP SPDH
IMT31818 599 I − − None 0 0
IMT32509 599 I + + α, β, δ 0 ++
IMT32513 599 I + + α, β, δ 0 ++
IMT36943 599 I + + α, β, δ 0 ++
IMT36947 599 I + + α, β, δ 1 ++
IMT36948 599 I + + α, β, δ 1 ++
IMT38116 599 I + + α, β, δ 0 ++
IMT39824 599 I − − None 0 0
IMT39825 599 I + + α, β, δ 0 ++
RKI5962 599 I + + α, β, δ 0 ++
RKI5963 599 I + + α, β, δ 0 ++
RKI5964 599 I + + α, β, δ 0 ++
IMT36945 49 II − − None 0 0
RKI5972 49 II + + α, β, δ 0 ++
IMT31819* 130 III − − None 0 0
IMT32510 130 III + Weak + Weak β 0 ++
IMT32929 130 III + Weak + β 1 ++
IMT34478 130 III + − None 1 0
IMT34479 130 III + + β, δ 1 ++
IMT34480 130 III + + β, δ 1 ++
IMT34488 130 III + + α, β, δ 0 ++
IMT34489 130 III − − None 0 0
IMT34491 130 III + + α, β, δ 0 ++
IMT36946 130 III + + α, β, δ 0 ++
IMT36950 130 III + + α, β, δ 0 ++
IMT38115 130 III + + α, β, δ 0 ++
IMT38119* 130 III + + α, β, δ 0 ++
IMT39816 130 III + + α, β, δ 0 ++
IMT39819 130 III + + α, β, δ 2 ++
IMT40506 130 III + + α, β, δ 1 ++
IMT41554 130 III + + α, β, δ 1 ++
RKI5965 130 III Weak + + α, β, δ 1 ++
RKI5966* 130 III − + β 0 0
RKI5967 130 III + + α, β, δ 0 ++
RKI5968 130 III + + α, β, δ 1 ++
IMT34485 1943 IV + + α, β, δ 0 ++
IMT36952 1943 IV − − None 2 0
IMT38113 1943 IV + − α, δ 0 ++
IMT39820 1943 IV + + α, β, δ 0 ++
IMT40504 1943 IV + + α, β, δ 0 ++
IMT40507 1943 IV + − α, δ 0 ++
RKI5969 1943 IV + + α, β, δ 0 ++
RKI5970 1943 IV + + α, β, δ 0 ++
RKI5971 1943 IV + + α, β, δ 0 ++
RKI5973 1943 IV Weak + − α, δ 2 ++
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tinct agr activity groups (i.e. 0, +, ++) which matched well with synergistic haemolysis on SBA (Fig. 4a) and the 
results of the colony spreading assay (Fig. 4b).
Isolates showing amino acid changes in the C-terminal DNA-binding domain of the AgrA response  regulator89 
such as IMT31818 (ΔN177), IMT39824 (F196S), IMT34478 (S215P) and IMT36952 (C199R) did not produce 
δ-haemolysin, indicating that these aberrations silenced the agr system. However, IMT34478 was still capable 
of colony spreading, suggesting residual or agr-independent PSM production by a mechanism that still needs 
to be established.
With respect to non-wt AgrC variants, RKI5966 (Q16H) showed a variation in the transmembrane 1 domain 
of the protein, while the aa exchange E216K in IMT32929 is located in the C-terminal dimerization/histidine 
phosphotransfer subdomain of the  protein90. These changes are prone to impair AgrC-mediated AIP sensing 
and signal  transduction90, and are therefore likely to cause the agr-negative phenotype observed in the isolates.
Further, comparative analysis of Hld production values with the CAMP test results confirmed that an active 
agr system is necessary to induce the lunar-shaped synergistic haemolysis on SBA, with Hld and/or PSMs known 
to contribute to the  phenotype67. With respect to β-haemolysin production, agr was shown to have a major impact 
on hlb  transcription91. However, this association is obviously not straightforward and applicable for all strains. 
Thus, high levels of Hlb were also detected in S. aureus isolates displaying low agr activity, such as  RN422086, 
which is in good agreement with the Hlb detection results obtained in our isolates (Supplemental Figure 2). 
Moreover, our data indicate that at least a weak agr activity is necessary to induce a Hlb-mediated β-haemolysis 
phenotype on SBA, even when the intracellular Hlb levels were apparently sufficient to induce haemolysis in 
corresponding agr wt-isolates (Supplemental Figure 2).
Production of many secreted enzymes involved in lipid and protein degradation and haemolysins are 
influenced or even directly controlled by agr. The main effector of this locus, RNAIII, is known to promote 
α-haemolysin expression on the transcriptional and post-transcriptional  level92. As expected, Hla production was 
not detected in isolates lacking the gene (IMT34489) and in those carrying hla frameshift mutations (IMT34479 
and IMT34480). Surprisingly, Hla abundance values measured in whole cells of isolates with intact hla genes 
did not correlate with the agr activity levels (Supplemental Figure 1). Also, for some of the isolates with AgrA/
AgrC aberrations and negative α-haemolysis on SBA (IMT31818, IMT32510, IMT32929, IMT36945, IMT39824, 
RKI5966, NE1532, and RN4220) we noticed intracellular Hla protein amounts that were comparable to that of 
agr-wt strains showing a haemolytic phenotype (Supplemental Figure 1). A study by Montgomery et al. confirmed 
notable agr-independent transcription of Hla in an agr-deficient strain (USA300 lineage), while the protein 
was not detected in the corresponding culture  supernants69, which is commonly explained by the promoting 
role of RNAIII for hla transcript  translation92. Since our Hlb and Hla protein abundances were measured from 
overnight-grown cells after washing with PBS, our results indicate that some agr-activity is needed for toxin 
release. Interestingly, extracellular vesicles released from cells of the USA300 lineage were found to contain  Hla93. 
In that particular study, PSMα was identified to promote biogenesis of extracellular vesicles filled with proteins by 
Figure 5.  Colony spreading assay results for mecC-S. aureus with different agr functionalities on soft agar 
plates. A TSA soft agar plate (0.24%) was inoculated with 2 µl overnight culture of S. aureus. Examples shown 
here include isolate RKI5966 associated with a weak agr functionality, which was not able to spread on semisolid 
agar plates, while isolate IMT38119 (strong agr functionality) showed spreading. As controls we have employed 
the standard laboratory strains RN4220 (weak agr functionality) and USA300 (strong agr functionality).
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destabilisation of the cytoplasmic  membrane93. Thus, is tempting to speculate that baseline agr-independent hla 
transcription and translation might occur in the variants, leading to intracellular accumulation of α-haemolysin. 
Lacking PSM activity (due to AgrA/C variations) might prevent release of Hla in the supernatant, resulting in 
the haemolysis-negative phenotypes observed. More experimental work, however, is needed to substantiate this 
hypothesis in the future.
Agr variants influence biofilm structure and density. Biofilm formation is a key factor in pathogen-
esis of persistent staphylococcal  infections94, and downregulation of agr is supposed to facilitate biofilm devel-
opment in  staphylococci50,95–97 with strain-specific differences occurring particularly among clinical  isolates98. 
When testing the mecC-MRSA isolates in a standard crystal violet-staining biofilm assay, we did not find an 
association between agr functionality and stable biofilm formation in polystyrene tissue culture plates (Table 2), 
which is in good agreement with previous findings in clinical MRSA clonal  lineages38. Generally, we found 
only a few biofilm-forming isolates by this assay, although biofilm-associated genes were present and intact in 
all strains. In comparison to S. epidermidis, S. aureus is known to show a much weaker biofilm detection per-
formance in the standard biofilm assay. Rather than suggesting a lower overall biofilm-forming capacity of S. 
aureus, the phenomenon may reflect a general mechanically instable contact of biofilm-associated S. aureus cells 
to inert surfaces, leading to removal of loosely attached biofilm structures upon washing of the plates. Indeed, 
Figure 6.  Agr activity and biofilm formation differences among mecC-MRSA belonging to clonal complex 
130. (a) Macroscopic camera image of an S. aureus isolate (mecC-MRSA) harbouring the agr III wild type (wt) 
variant (IMT38119) grown in a 24-well plate and (b) the confocal laser scanning picture showing the biofilm 
profile at the indicated spot (red square). (c) Isolate harbouring a agr III variant (non-wt agrC variant) lacking 
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when using CLSM imaging, which does not involve washing of the cover slips, we detected visible biofilms, at 
least in the three CC130 isolates analysed (Fig. 6). Interestingly, strains possessing different agr activity levels 
displayed differences regarding biofilm thickness and architecture. Thus, while the WT-agr isolate formed a well-
organized biofilm (Fig. 6b), the two agr-deficient variants displayed a much higher biofilm mass which, however, 
appeared less-structured (Fig. 6d,f). This might be due to the lack of agr-dependent production of PSMs which 
were previously shown to play an eminent role in functional biofilm  architecture99,100. S. aureus biofilm forma-
tion is a complex and highly dynamic process which comprises, according to a recently newly defined five-stage 
model, attachment, multiplication, exodus, maturation and dispersal of the  biofilm101. Apart from its function in 
maturation and dispersal (involving agr-controlled proteases and PSMs), agr also plays a significant role during 
initial attachment by facilitating (in the early growth stage) expression of cell wall-anchored proteins that medi-
ate host matrix protein binding as well as contact to abiotic  surfaces102. We currently speculate that the loose 
biofilm structure in the CC130 agr-variants might be associated with a diminished initial attachment of the 
bacteria to the surface and/or to each other. However, it is conceivable that other processes known to shape the 
biofilm architecture such as programmed autolysis and eDNA  release103 might be (indirectly) affected by the Agr 
variations as well. But, clearly more experimental work is needed to substantiate this hypothesis.
Adaptation strategies of mecc‑MRSA might involve agr defectiveness and carriage of agr‑inde‑
pendent virulence factors. Evolution and changes of bacterial virulence is highly dynamic and difficult to 
 predict104,105. Attenuated virulence favouring host colonization and/or persistence of infection (e.g. small colony 
variants) is a common concept in bacterial  evolution106–108. The mecC-MRSA lineages CC130, CC49, CC1943 
and CC599 were obviously not among those CC’s frequently reported for nasal colonization in humans and ani-
mals such as CC22 and  CC398109–112. Consequently, other strategies might promote their viability or even spread 
among mammalian hosts and the environment. On one hand, the disability to produce the agrD-encoded auto-
inducer peptide (AIP) may prevent costly competition of invading strains with an “incompatible” agr system 
harboured by other S. aureus lineages or even other staphylococcal species in a particular  host113. One the other 
hand, presence of a compatible AIP system allows the cells to take advantage of the agr-induced factors produced 
by co-habiting  staphylococci29. A highly instructive study, using a wax moth larva virulence model, revealed 
that a functional agr system is necessary for a cooperative and beneficial “behaviour” of the local population, 
while agr defective mutants exploit (“cheat”) on the cells with a functional agr system, allowing them to prevail 
when grown in mixed populations with  cooperators113. Based on earlier published results of growth competi-
tion  experiments113, 114, an increased viability of agr defective S. aureus mutants among resident staphylococci of 
different host species seems to be likely. This view is further supported by a recent study, showing that distinct 
external stress conditions drive the selection of Agr quorum-sensing mutants that may confer a fitness advantage 
to the S. aureus  population115.
Unspecific and unregulated T-cell stimulators (superantigens) such as enterotoxins, enterotoxin-like proteins, 
and the toxic shock syndrome toxin contribute to host cell damages inducible by S. aureus. Combinations of 
genes encoding these superantigens were identified in varying frequencies for all four lineages reported on here 
(Fig. 1). With respect to  enterotoxins116, Enterotoxin C (SEC), which is commonly located on a SaPI (reviewed 
 in49), was identified in isolates belonging to CC130, CC599 and CC1943. However, SEC production requires 
agr-depending rot  degradation117, which is defective in some of the isolates reported on here. While classical 
enterotoxins such as SEA-C are regulated by the agr system, the “novel” enterotoxins and variants of the toxic 
shock syndrome toxin seem to be agr independent (reviewed  in49). In line with this, we have shown expression 
of the protein encoded by tst-bov in isolates showing lacking detectable agr activity (Fig. 1, Table 2), exemplified 
by isolates IMT31818 and IMT39824. The variants of tst-bov were harboured by S. aureus pathogenicity islands 
showing mosaic structures of known and novel SaPIs, an observation which has been reported (e.g. for human 
clinical isolates)  before118.
conclusion
Comparative genomics of the agr encoding region allow identification of variants deviating from the wildtype in 
mecC-MRSA belonging to CC130, CC599, CC49 and CC1943, and subsequent proteomics revealed the capability 
of each altered agr system to transcribe RNAIII, which was directly mirrored by the corresponding Hld protein 
values. Our research indicates that mecC-MRSA with agr variations are defective for agr-depending quorum 
sensing, harbour additional agr-independent virulence factors and exhibit varying biofilm properties as a likely 
part of their survival strategy. In bacteria, adaptation to a changing environment is often associated with the 
selection for mutations in (virulence factor) genes that become dispensable or disadvantageous in the novel niche 
(reviewed  in104). This concept can obviously be extended to global regulators such as the agr quorum-sensing 
system as well, resulting in pleiotropic effects and the generation of phenotypic heterogeneity that might further 
support the establishment of emerging clonal lineages in new hosts and niches.
Data availability
Genomic sequencing data used are available for download from the National Center for Biotechnology Infor-
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